← Eichor
Condition: Astrocytic Tumor Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Astrocytic Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard
Phase 1 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07179328Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume
NA · 23 location(s) · Cliniques universitaires Saint-Luc- Université Catholique de · NCT06719440Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide
Phase 2 · 7 location(s) · Hopital Foch · NCT04945148Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma
Phase 2 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT04863950Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
NA · 1 location(s) · Northwell Health · NCT05954858Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
Phase 2 · 1 location(s) · Northwestern University · NCT05864534Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 · 8 location(s) · Orano Med Theranostics, SAS · NCT05283330ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Phase 2 · 22 location(s) · University of Birmingham · NCT05629702Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT06815432Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Phase 1/Phase 2 · 1 location(s) · University of Miami · NCT05956821Lerapolturev (PVSRIPO) in GBM
Phase 2 · 1 location(s) · Darell Bigner · NCT06177964131I-TLX-101 for Treatment of Newly Diagnosed Glioblastoma (IPAX-2)
Phase 1 · 6 location(s) · Telix Pharmaceuticals (Innovations) Pty Limited · NCT05450744A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
Phase 1/Phase 2 · 2 location(s) · M.D. Anderson Cancer Center · NCT06672575A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Pat
EARLY_Phase 1 · 1 location(s) · Nader Sanai · NCT07268053Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
Phase 1/Phase 2 · 1 location(s) · Northwell Health · NCT01269853IA Carboplatin + Radiotherapy in Relapsing GBM
Phase 1/Phase 2 · 1 location(s) · Université de Sherbrooke · NCT03672721The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06146725Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion
NA · 1 location(s) · Shengjing Hospital · NCT05990244Predictive Value of Soluble CD146 in Glioblastoma Patients
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06001281Study of Recombinant Human Endostatin Combined with Temozolomide and Irinotecan in Recurrent Gliomas
Phase 2 · 1 location(s) · Beijing Sanbo Brain Hospital · NCT04267978A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
Phase 1/Phase 2 · 60 location(s) · Bayer · NCT06914128Study of Pembrolizumab and M032 (NSC 733972)
Phase 1/Phase 2 · 1 location(s) · University of Alabama at Birmingham · NCT05084430Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Phase 1/Phase 2 · 15 location(s) · Tango Therapeutics, Inc. · NCT06810544A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in
Phase 1 · 1 location(s) · Universitair Ziekenhuis Brussel · NCT06097975Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07462507IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
Phase 1 · 1 location(s) · University of Florida · NCT05353530Methimazole in Patients With Progressive Glioblastoma
Phase 2 · 1 location(s) · Case Comprehensive Cancer Center · NCT05607407The PROGRAM-study: Awake Mapping Versus Asleep Mapping Versus No Mapping for Glioblastoma Resections
Phase N/A · 8 location(s) · Erasmus Medical Center · NCT04708171Glutamate Inhibitors in Glioblastoma
Phase 1/Phase 2 · 1 location(s) · University of Zurich · NCT05664464
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.